• 제목/요약/키워드: hematopoietic stem cell

검색결과 257건 처리시간 0.024초

AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells

  • Im, Jin Young;Min, Woo-Kie;Park, Min Hee;Kim, NamOh;Lee, Jong Kil;Jin, Hee Kyung;Choi, Je-Yong;Kim, Shin-Yoon;Bae, Jae-Sung
    • BMB Reports
    • /
    • 제47권8호
    • /
    • pp.439-444
    • /
    • 2014
  • Inhibition of an increase of osteoclasts has become the most important treatment for osteoporosis. The CXCR4 antagonist, AMD3100, plays an important role in the mobilization of osteoclast precursors within bone marrow (BM). However, the actual therapeutic impact of AMD3100 in osteoporosis has not yet been ascertained. Here we demonstrate the therapeutic effect of AMD3100 in the treatment of ovariectomy-induced osteoporosis in mice. We found that treatment with AMD3100 resulted in direct induction of release of SDF-1 from BM to blood and mobilization of hematopoietic stem/progenitor cells (HSPCs) in an osteoporosis model. AMD3100 prevented bone density loss after ovariectomy by mobilization of HSPCs, suggesting a therapeutic strategy to reduce the number of osteoclasts on bone surfaces. These findings support the hypothesis that treatment with AMD3100 can result in efficient mobilization of HSPCs into blood through direct blockade of the SDF-1/CXCR4 interaction in BM and can be considered as a potential new therapeutic intervention for osteoporosis.

Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro

  • Park, Jung-Sun;Park, Soo-Young;Cho, Hyun-Il;Sohn, Hyun-Jung;Kim, Tai-Gyu
    • IMMUNE NETWORK
    • /
    • 제11권3호
    • /
    • pp.182-189
    • /
    • 2011
  • Background: Cytotoxic T lymphocytes (CTLs) appear to play an important role in the control and prevention of human cytomegalovirus (HCMV) infection. The pp65 antigen is a structural protein, which has been defined as a potential target for effective immunity against HCMV infection. Incorporation of an 11 amino acid region of the HIV TAT protein transduction domain (Tat) into protein facilitates rapid, efficient entry into cells. Methods: To establish a strategy for the generation of HCMV-specific CTLs in vitro, recombinant truncated N- and C-terminal pp65 protein (pp65 N&C) and N- and C-terminal pp65 protein fused with Tat (Tat/pp65 N&C) was produced in E.coli system. Peripheral blood mononuclear cells were stimulated with dendritic cells (DCs) pulsed with pp65 N&C or Tat/pp65 N&C protein and immune responses induced was examined using IFN-${\gamma}$ ELISPOT assay, cytotoxicity assay and tetramer staining. Results: DCs pulsed with Tat/pp65N&C protein could induce higher T-cell responses in vitro compared with pp65N&C. Moreover, the DCs pulsed with Tat/pp65 N&C could stimulate both of $CD8^+$ and $CD4^+$ T-cell responses. The T cells induced by DCs pulsed with Tat/pp65 N&C showed higher cytotoxicity than that of pp65-pulsed DCs against autologous lymphoblastoid B-cell line (LCL) expressing the HCMV-pp65 antigen. Conclusion: Our results suggest that DCs pulsed with Tat/pp65 N&C protein effectively induced pp65-specific CTL in vitro. Tat fusion recombinant protein may be useful for the development of adoptive T-cell immunotherapy and DC-based vaccines.

조혈모세포이식병동 간호사의 자율성과 직무만족도 (Autonomy and Job Satisfaction of the Nurses in the Hematopoietic Stem Cell Transplantation Ward)

  • 정현옥;채경미
    • 디지털융복합연구
    • /
    • 제16권3호
    • /
    • pp.363-373
    • /
    • 2018
  • 본 연구는 조혈모세포이식병동 간호사의 자율성과 직무만족도를 파악하고, 자율성과 직무만족도와의 상관관계를 규명하기 위한 조사연구이다. 국내 7개의 대학병원에 근무하는 간호사 79명을 대상으로 2013년 5월 20일부터 6월 4일까지 설문조사를 실시하였다. 분석방법은 SPSS 14.0을 이용하여 t-test, ANOVA, Pearson correlation coefficient를 실시하였다. 자율성 평균은 $165.47{\pm}19.56$점, 직무만족도 평균은 $3.15{\pm}0.35$점으로 나타났다. 자율성과 직무만족도는 상관관계를 보이지 않았으나, 직무만족도의 하부영역 중 자율성영역(r=.273)과 상호작용영역(r=.257)은 자율성과 유의한 정적 상관관계를 보였다. 이에 조혈모세포이식병동 간호사의 직무만족도 향상을 위해서 직무만족도의 하부영역인 자율성을 높일 필요가 있을 것이다. 따라서 본 연구결과는 조혈모세포이식병동 간호사들의 자율성과 직무만족도를 증가시킬 수 있는 교육과 정책프로그램을 개발에 유용한 기초자료로 이용될 수 있다.

Expression of Gpnmb in NK Cell Development from Hematopoietic Stem Cells

  • Shin, Na-Ra;Lee, Ji-Won;Lee, Ji-Won;Jeong, Mi-Ra;Kim, Mi-Sun;Lee, Suk-Hyung;Yoon, Suk-Ran;Chung, Jin-Woong;Kim, Tae-Don;Choi, In-Pyo
    • IMMUNE NETWORK
    • /
    • 제8권2호
    • /
    • pp.53-58
    • /
    • 2008
  • Background: Molecular mechanisms of natural killer (NK) cell development from hematopoietic stem cells (HSCs) have not been clearly elucidated, although the roles of some genes in NK cell development have been reported previously. Thus, searching for molecules and genes related NK cell developmental stage is important to understand the molecular events of NK cell development. Methods: From our previous SAGE data-base, Gpnmb (Glycoprotein non-metastatic melanoma protein B) was selected for further analysis. We confirmed the level of mRNA and protein of Gpnmb through RT-PCR, quantitative PCR, and FACS analysis. Then we performed cell-based ELISA and FACS analysis, to know whether there are some molecules which can bind to Gpnmb. Using neutralizing antibody, we blocked the interaction between NK cells and OP9 cells, and checked IFN-${\gamma}$ production by ELISA kit. Results: Gpnmb expression was elevated during in vitro developmental stage and bound to OP9 cells, but not to NK precursor cells. In addition, we confirmed that the levels of Gpnmb were increased at NK precursor stage in vivo. We confirmed syndecan4 as a candidate of Gpnmb's binding molecule. When the interaction between NK cells and OP9 cells were inhibited in vitro, IFN-${\gamma}$ production from NK cells were reduced. Conclusion: Based on these observations, it is concluded that Gpnmb has a potential role in NK cell development from HSCs.

Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model

  • Park, Min Hee;Jung, In Kyung;Min, Woo-Kie;Choi, Jin Ho;Kim, Gyu Man;Jin, Hee Kyung;Bae, Jae-sung
    • BMB Reports
    • /
    • 제50권8호
    • /
    • pp.417-422
    • /
    • 2017
  • Cisplatin is the most effective and widely used chemotherapeutic agent for many types of cancer. Unfortunately, its clinical use is limited by its adverse effects, notably bone marrow suppression leading to abnormal hematopoiesis. We previously revealed that neuropeptide Y (NPY) is responsible for the maintenance of hematopoietic stem cell (HSC) function by protecting the sympathetic nervous system (SNS) fibers survival from chemotherapy-induced bone marrow impairment. Here, we show the NPY-mediated protective effect against bone marrow dysfunction due to cisplatin in an ovarian cancer mouse model. During chemotherapy, NPY mitigates reduction in HSC abundance and destruction of SNS fibers in the bone marrow without blocking the anticancer efficacy of cisplatin, and it results in the restoration of blood cells and amelioration of sensory neuropathy. Therefore, these results suggest that NPY can be used as a potentially effective agent to improve bone marrow dysfunction during cisplatin-based cancer therapy.

The maintenance mechanism of hematopoietic stem cell dormancy: role for a subset of macrophages

  • Cheong-Whan Chae;Gun Choi;You Ji Kim;Mingug Cho;Yoo-Wook Kwon;Hyo-Soo Kim
    • BMB Reports
    • /
    • 제56권9호
    • /
    • pp.482-487
    • /
    • 2023
  • Hematopoiesis is regulated by crosstalk between long-term repopulating hematopoietic stem cells (LT-HSCs) and supporting niche cells in the bone marrow (BM). Here, we describe the role of KAI1, which is mainly expressed on LT-HSCs and rarely on other hematopoietic stem-progenitor cells (HSPCs), in niche-mediated LT-HSC maintenance. KAI1 activates TGF-β1/Smad3 signal in LT-HSCs, leading to the induction of CDK inhibitors and inhibition of the cell cycle. The KAI1-binding partner DARC is expressed on macrophages and stabilizes KAI1 on LT-HSCs, promoting their quiescence. Conversely, when DARC+ BM macrophages were absent, the level of surface KAI1 on LT-HSCs decreases, leading to cell-cycle entry, proliferation, and differentiation. Thus, KAI1 acts as a functional surface marker of LT-HSCs that regulates dormancy through interaction with DARC-expressing macrophages in the BM stem cell niche. Recently, we showed very special and rare macrophages expressing α-SMA+ COX2+ & DARC+ induce not only dormancy of LT-HSC through interaction of KAI1-DARC but also protect HSCs by down-regulating ROS through COX2 signaling. In the near future, the strategy to combine KAI1-positive LT-HSCs and α-SMA/Cox2/DARC triple-positive macrophages will improve the efficacy of stem cell transplantation after the ablative chemo-therapy for hematological disorders including leukemia.

골수 미세환경에서 조혈줄기세포의 기능조절에 대한 고찰- 현재 및 새로운 개념 (Hematopoietic Stem Cells and Bone Marrow Microenvironment: Current and Emerging Concepts)

  • 이원종;박성현;박준희;오성환;이동준
    • 생명과학회지
    • /
    • 제32권6호
    • /
    • pp.468-475
    • /
    • 2022
  • 줄기세포와 전구세포 사이의 기능 분석은 여러 조직 특히 혈액에서 잘 확립되어 있다. 특히 조혈줄기세포는 골수 니쉬에서 자가재생능 및 재구성능을 가지고 있으며, 골수 내 기질세포는 조직 기능 조절에 큰 영향을 미친다. 최근 연구에서는 포유동물 줄기세포의 기능은 니쉬 세포 내에서 실험적으로 처음 증명되었고, 특히 미세환경에 의해 종양발생이 가능하다는 증거를 나타내고 있다. 고대에서부터 뼈와 피의 관계는 생체 내 필수불가결인 관계로 진화 과정을 거쳐 포유류의 줄기세포에 대해 최초로 제안되었고, 실험적으로 증명된 니쉬세포를 포함한 미세환경과의 복잡한 상호 관계를 규명하였다. 여러 골수 기질세포는 조혈줄기세포의 기능 조절을 하며, 일부의 기능장애는 골수 이형성 및 백혈병을 유발할 수 있다. 현재까지 여러 기질세포에 대한 맵핑이 되지 않아 현재 많은 연구자들이 단일 분자 수준에서 개개의 기질세포 유형을 파악하는 데이터가 필요하다고 주장하고 있으며 이를 바탕으로 골수 내 조혈줄기세포의 특정 기능을 파악할 수 있다고 볼 수 있다. 따라서 본 총설을 통해 조혈줄기세포 및 미세환경에 대한 이전 연구들의 흥미로운 문제를 논의하고, 조혈줄기세포와 골수 니쉬에 대한 현재 및 새로운 개념을 요약하고자 한다.

Suspension culture system을 이용한 hematopoietic stem cell의 expansion

  • 권준;김미정;김병수;박홍우
    • 한국생물공학회:학술대회논문집
    • /
    • 한국생물공학회 2001년도 추계학술발표대회
    • /
    • pp.475-478
    • /
    • 2001
  • 체외에서 hematopoietic cells의 배양은 필수이식으로 하여금 hematopoietic malignancies로 인해 고통받는 환자들을 치료할 수 있다. 본 실험에서는 골수의 초기 농도$1.5{\times}10^6cells/ml$로 하여 IL-3(5ng/ml), SCF(5ng/ml)과 FL(25ng/ml)의 성장 인자들을 첨가함으로써 bone marrow의 전체 cell의 증식은 생성시키지 못 했지만 LTC-IC는 3.6배의 증식을 가져왔다.

  • PDF

다층모형을 적용한 조혈모세포이식 환자의 삶의 질 변화 영향요인 (Factors Influencing Changes in Quality of Life in Patients undergoing Hematopoietic Stem Cell Transplantation: A Longitudinal and Multilevel Analysis)

  • 송지은;소향숙
    • 대한간호학회지
    • /
    • 제45권5호
    • /
    • pp.694-703
    • /
    • 2015
  • Purpose: This study was a prospective longitudinal study to identify changes in quality of life in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). It was based on Roy's adaptation model. Methods: The questionnaires were administered before HSCT, 30 and 100 days after HSCT. Of the 48 potentially eligible patients, 44 (91.7%) participated in the study and 40 (90.9%) completed the questionnaires at 100 days after HSCT. Multilevel analysis was applied to analyze changes in quality of life. Results: Overall, quality of life showed a decreasing tendency from pre-HSCT to 100 days after HSCT. The adaptation level of participants was compensatory. Type of conditioning was the significant factor influencing quality of life before HSCT (${\beta}_{00}$=79.92, p <.001; ${\beta}_{01}$= - 12.64, p <.001) and the change rate of quality of life (${\beta}_{10}$= - 1.66, p =.020; ${\beta}_{11}$=2.88, p =.014). Symptom severity (${\beta}_{20}$= - 1.81, p =.004), depression (${\beta}_{30}$= - 0.58, p =.001), social dependency (${\beta}_{40}$= - 0.35, p =.165), and loneliness (${\beta}_{50}$= - 0.23, p =.065) had a negative effect on changes in quality of life. Symptom severity and depression were statistically significant factors influencing changes in quality of life. Conclusion: According to the results of this study, the development of nursing intervention is needed to improve quality of life in patients undergoing allogeneic hematopoietic stem cell transplantation in the early immune reconstruction period. The interventions should include programs to enhance coping capacity and programs to help control symptom severity and depression. Also these interventions need to be started from the beginning of HSCT and a multidisciplinary approach would be helpful.